Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116271 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Fu-Li Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Pathology and Intelligent Diagnosis of Jiangxi Province, Department of Pathology and Molecular Pathology Institute, The F…. Hauptthemen laut MEDLINE: Luteolin, X-Linked Inhibitor of Apoptosis Protein, Mitochondria, Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
INTRODUCTION: PANoptosis, an inflammatory cell death pathway that integrates pyroptosis, apoptosis, and necroptosis, contributes critically to the pathogenesis of inflammatory diseases including hemophagocytic lymphohistiocytosis (HLH). However, the molecular regulation of PANoptosis and its pharmacological intervention remain poorly defined. OBJECTIVES: This study aimed to investigate the regulatory role of XIAP in PANoptosis and to evaluate the therapeutic potential of luteolin, a natural flavonoid, as a pharmacological inhibitor of PANoptosis. METHODS: Murine macrophage models were used to assess PANoptosis induction and inhibition. Structural and biochemical approaches were applied to determine the interaction between luteolin and XIAP. Mitochondrial function, ROS accumulation, oxidized mitochondrial DNA, and z-DNA generation were examined, while autophagy was evaluated as a modulatory mechanism. Therapeutic efficacy was further validated in a poly(I:C)/LPS-induced HLH mouse model. RESULTS: XIAP was identified as an essential component of the PANoptosome complex, and its knockdown abolished PANoptosis formation. Luteolin directly bound to XIAP, destabilized its structure, and disrupted its interaction with PANoptosome, thereby blocking PANoptosome assembly. Luteolin preserved mitochondrial integrity, reduced ROS accumulation, and inhibited the generation of oxidized mtDNA and z-DNA. Importantly, luteolin enhanced autophagic clearance of damaged mitochondria by relieving XIAP-mediated suppression of autophagy. In vivo, luteolin treatment significantly attenuated systemic inflammation, protected organ function, and improved survival in HLH mice, effects associated with diminished PANoptosome formation and reduced z-DNA accumulation. CONCLUSIONS: This study establishes XIAP as a central regulator of PANoptosis and demonstrates luteolin as a natural inhibitor targeting XIAP to block PANoptosome assembly and mitochondrial dysfunction. These findings provide a novel pharmacological strategy for treating PANoptosis-driven inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Precision Pathology and Intelligent Diagnosis of Jiangxi Province, Department of Pathology and Molecular Pathology Institute, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University…
- Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Shi, F. L., Lv, Y. F., Luo, S. Q., Sun, Y. X., Wen, X. Q., Ren, Y. X., Yang, Y. X., Yu, P., Chen, Q. F., Yang, X. H., Xu, S., Qing, J., Ouyang, D. Y., & Li, J. M. (2026). Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116271
Vancouver
Shi FL, Lv YF, Luo SQ, Sun YX, Wen XQ, Ren YX, et al. Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116271
BibTeX
@article{Shi2026,
author = {Shi, Fu-Li and Lv, Yang-Feng and Luo, Shi-Qi and Sun, Yu-Xuan and Wen, Xiang-Qiong and Ren, Yue-Xiang and Yang, Yu-Xing and Yu, Peng and Chen, Qiong-Feng and Yang, Xian-He and Xu, Shan and Qing, Jie and Ouyang, Dong-Yun and Li, Jian-Ming},
title = {Luteolin mitigates inflammatory organ injury by targeting XIAP to block PANoptosis and mitochondrial dysfunction},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116271}
}
EUVIMED